MacroGenics, Inc.
MGNX
$1.74
$0.0955.79%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 165.49M | 154.05M | 149.96M | 141.33M | 41.02M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 165.49M | 154.05M | 149.96M | 141.33M | 41.02M |
| Cost of Revenue | 144.97M | 149.83M | 146.29M | 149.43M | 140.50M |
| Gross Profit | 20.52M | 4.22M | 3.67M | -8.10M | -99.49M |
| SG&A Expenses | 61.93M | 67.06M | 71.05M | 55.80M | 54.10M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 243.52M | 253.50M | 260.54M | 248.42M | 237.81M |
| Operating Income | -78.03M | -99.45M | -110.58M | -107.09M | -196.79M |
| Income Before Tax | -35.35M | -54.87M | -66.02M | -97.62M | -136.37M |
| Income Tax Expenses | 1.05M | 944.00K | 944.00K | -- | -- |
| Earnings from Continuing Operations | -36.40 | -55.81 | -66.97 | -97.62 | -136.37 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -36.40M | -55.81M | -66.97M | -97.62M | -136.37M |
| EBIT | -78.03M | -99.45M | -110.58M | -107.09M | -196.79M |
| EBITDA | -70.46M | -91.98M | -103.04M | -99.71M | -189.29M |
| EPS Basic | -0.57 | -0.89 | -1.07 | -1.57 | -2.19 |
| Normalized Basic EPS | -0.71 | -0.91 | -1.02 | -0.98 | -1.37 |
| EPS Diluted | -0.58 | -0.89 | -1.08 | -1.58 | -2.19 |
| Normalized Diluted EPS | -0.71 | -0.91 | -1.02 | -0.98 | -1.37 |
| Average Basic Shares Outstanding | 251.63M | 251.16M | 250.48M | 249.74M | 248.98M |
| Average Diluted Shares Outstanding | 251.75M | 251.28M | 250.60M | 249.86M | 249.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |